Noninvasive Prenatal Detection of Fetal Trisomy 18 by Epigenetic Allelic Ratio Analysis in Maternal Plasma: Theoretical and Empirical Considerations
Author(s) -
Tong Yu,
Chunming Ding,
Rossa W. K. Chiu,
Ageliki Gerovassili,
S Chim,
Tak Yeung Leung,
Tse Ngong Leung,
Tze Kin Lau,
K. H. Nicolaides,
Y. M. Dennis Lo
Publication year - 2006
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2006.076851
Subject(s) - epigenetics , dna methylation , cell free fetal dna , biology , fetus , aneuploidy , bisulfite sequencing , allele , trisomy , genetics , andrology , prenatal diagnosis , microbiology and biotechnology , pregnancy , chromosome , gene , medicine , gene expression
The discovery of cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis. However, the use of maternal plasma fetal DNA for the direct detection of fetal chromosomal aneuploidies has not been reported. We postulate that the aneuploidy status of a fetus could be revealed by an epigenetic allelic ratio approach, i.e., by analyzing the allelic ratio of a single-base variation present within DNA molecules exhibiting a placental-specific epigenetic signature in maternal plasma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom